More than 100 industry players and over 60 non-industry players currently claim to manufacture diffe

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry


To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this link


The USD 11 billion (by 2030) financial opportunity within the cell therapy manufacturing market has been analyzed across the following segments:

Type of therapy

T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)

Dendritic cell therapies

Tumor cell therapies

NK cell therapies

Stem cell therapies

  • Source of cells
  • Autologous
  • Allogeneic

Scale of operation

  • Clinical
  • Commercial

Purpose of manufacturing

  • Contract manufacturing
  • In-house manufacturing

Key geographical regions

North America


Asia Pacific

Rest of the world


The Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030 report features the following companies, which we identified to be key players in this domain: 

  • BioNTech Innovative Manufacturing Services
  • Cell Therapies
  • Cell and Gene Therapy Catapult
  • Center for Cell and Gene Therapy, Baylor College of Medicine
  • Centre for Cell Manufacturing Ireland, National University of Ireland
  • Clinical Cell and Vaccine Production Facility, University of Pennsylvania
  • Cognate BioServices
  • Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
  • Hitachi Chemical
  • KBI Biopharma
  • Laboratory for Cell and Gene Medicine, Stanford University
  • Lonza
  • MaSTherCell
  • Molecular and Cellular Therapeutics, University of Minnesota
  • Newcastle Cellular Therapies Facility, Newcastle University
  • Nikon CeLL innovation
  • Rayne Cell Therapy Suite, King’s College London
  • Roslin Cell Therapies
  • Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
  • Sydney Cell and Gene Therapy
  • WuXi Advanced Therapies


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Regulatory Landscape 

6. Roadmaps for Overcoming Existing Challenges


7. Automation Technologies for Cell Therapy Manufacturing

8. Profiles: Industry Players

9. Profiles: Non-Industry Players

10. Role of Non-Profit Organizations

11. Partnerships

12. Facility Expansions

13. Capacity Analysis

14. Demand Analysis

15. Cost Price Analysis

16. Make Versus Buy Decision Making Framework

17. Market Sizing and Opportunity Analysis


18. Key Insights

19. SWOT Analysis


20. Conclusion


21. Survey Analysis


22. Interview Transcripts


23. Appendix 1: Tabulated Data


24. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415  

This post was created with our nice and easy submission form. Create your post!

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

What do you think?

The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 203

Synopsis 2021 International Online Summit is Set for February 20 and 21

Synopsis 2021 International Online Summit is Set for February 20 and 21